Kawashima S, Inozume T, Kawazu M, Ueno T, Nagasaki J, Tanji E, Honobe A, Ohnuma T, Kawamura T, Umeda Y, Nakamura Y, Kawasaki T, Kinuwa Y, Yamasaki O, Fukushima S, Ikehara Y, Mano H, Suzuki Y, Nishikawa H, Matsue H, Togashi Y. (2021)
TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment.
J Immunother Cancer. 2021;9:e003134.
PMID: 34795004 DOI: https://doi.org/10.1136/jitc-2021-003134
↑ 川島秀介医師 学位請求論文
↑ 日本皮膚悪性腫瘍学会賞(The Japanese Skin Cancer Society Award、石原・池田賞)